News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

VIVUS (VVUS) Settlement Could Clue In Orexigen (OREX) Investors



7/21/2017 6:35:10 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
The prescription anti-obesity sector has had its challenges over the years. After more than a decade with no new treatments for obesity, three companies developed, received approval for, and launched anti-obesity drugs a few years ago. Investors thought that a new anti-obesity treatment was a "no-brainer" and piled into Vivus (VVUS), Arena Pharmaceuticals (ARNA), and Orexigen (OREX). Ultimately, each company struggled in a big way to find enough patients to drive sales to respectable levels.

Read at Seeking Alpha


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES